To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
Senate Finance Committee Wants Trump Action on DIR Fees
image description here Eight pharmacy groups lauded a letter urging the Trump administration to reform direct and indirect remuneration (DIR) fees.

More
 
MS Drugs in the Pipeline
image description here Current phase 3 studies investigative novel, preventative approaches.

More
 
Tenapanor Approved for Adults with IBS-C
image description here NHE3 inhibitor administered as 50 mg oral tablets

More
 
ADVERTISEMENT
4 core values your pharmacy must embrace
In this webinar, business expert Jennifer Zilka reveals how community visibility and marketing, in-store customer experiences, smart negotiation with managed care and data-driven management interconnect to lift pharmacies above the competition. Register now!
 
Read More
 
5 New Pharmacy Rules and Regulations to Watch
Preventing Errors with High-Risk Medications
Vaccinations in the Pipeline
Business Performance Tools that Turn Data into Meaningful Metrics
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.